Tech Company Financing Transactions
Roca Therapeutics Funding Round
On 9/26/2022, Roca Therapeutics raised Seed investment from Bpifrance, Eurobiomed and Paca-Est Incubator.
Transaction Overview
Company Name
Announced On
9/26/2022
Transaction Type
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to develop its Lead Clinical candidate RCT001 (Metastatic Uveal Melanoma) until IND/CTA readiness in 2023, and to further expand the company's portfolio of assets with the nomination of a second clinical candidate against Neovascular Glaucoma associated to Uveal melanoma.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Institut Delvalle 27 rue du Professeur Delvalle
Nice, 06000
FR
Nice, 06000
FR
Phone
Website
Email Address
Overview
Roca Therapeutics is a VC financed biotechnology start-up dedicated to the development of First In Class Small molecules. Located in Nice (France), Roca Therapeutics is a spin-off from Nice University and SATT Sud Est, incubated by the PACA-Est incubator. Roca has an internationally recognized team of Directors and Advisors with a strong track record of Translational Research and Drug Development in Oncology, Ophtalmology and Immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Zaki Sellam
Chief Executive Officer
Maeva Dufies
Browse more venture capital transactions:
Prev: 9/26/2022: Well-Link Technologies venture capital transaction
Next: 9/26/2022: Signzy venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs